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Abstract 
The national AIDS response of South Sudan is coordinated by the South Sudan HIV and AIDS 
Commission (SSAC) that was established in 2006 by a presidential decree. The mandate of 
SSAC is to coordinate the development of policy frameworks and strategies for curbing and 
combating the spread of HIV. SSAC works closely with the Division of HIV/AIDS whose 
mandate is to develop health sector response to HIV/AIDS by ensuring the accessibility of 
quality, equitable HIV prevention services, treatment, care and support for the people infected 
with and affected by HIV/AIDS.  
 
With leadership from SSAC and the Ministry of Health (MOH), the Government of South Sudan 
(GoSS) developed the Southern Sudan HIV/AIDS Strategic Framework (SSHASF 2008-2012) 
which is currently driving HIV/AIDS response in the country. The strategic framework 
comprehensively addresses HIV/AIDS prevention, treatment, care and support services in the 
post-conflict context, with an overall goal of reducing HIV transmission and mitigating the 
impact of HIV/AIDS through improvement of the quality of life of those infected and affected by 
HIV/AIDS. The SSHASF clearly articulates the need for targeting specific populations in a 
multi-sectoral response: women and girls, youth, sex workers, orphans and vulnerable children. 
Also outlined in the SSHASF is an HIV policy for other specific vulnerable population settings 
such as the workplace, schools and prisons. 
 
SSAC and MOH have developed a number of guidelines and policy documents in the past few 
years, including: HIV/AIDS Behavior Change and Communication (BCC) strategy (2008), 
HIV/AIDS Monitoring and Evaluation (M&E) framework (2008), Guidelines for Anti-retroviral 
therapy (ART) use in adults and children (Revised 2010), Guidelines for Voluntary Counseling 
and Testing (VCT) (2008), Guidelines for Prevention of Mother-to-Child-Transmission 
(PMTCT) 2010, National Condom Strategy. 
 
With permission from SSAC chairperson, Dr. Esterina Novello, I have participated with 
the National HIV/AIDS Response Division to do my field experience as follows: Reviewed 
HIV/AIDS strategic framework for prevention and control and conducted a field work; reviewed 
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the strategic framework for HIV/AIDS treatment, care and support for infected and affected 
individuals and conducted a field work; reviewed and fully understood the risk factors for 
transmission and continuing spread of HIV/AIDS among the South Sudanese people. 
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Chapter 1 - Overview of South Sudan 
 
 A. General Overview  
 
 
 
 
South Sudan, officially the Republic of South Sudan and previously known as Southern 
Sudan, is a landlocked country in east-central Africa that is part of the United Nations sub-
region of Eastern Africa. Its current capital is Juba, which is also its largest city; the capital 
city is planned to be moved to the more centrally located Ramciel in the future. South Sudan 
is bordered by Ethiopia to the east, Kenya to the southeast, Uganda to the south, the 
Democratic Republic of the Congo to the southwest, the Central African Republic to the west 
and Sudan to the north. It includes the vast swamp region of the Sudd, formed by the White 
Nile and known locally as the Bahr al Jabal. 
The modern states of South Sudan and Sudan were part of Egypt under the Muhammad Ali 
Dynasty, later being governed as an Anglo-Egyptian condominium until Sudanese 
independence was achieved in 1956. Following the First Sudanese Civil War, the Southern 
Sudan Autonomous Region was formed in 1972 and lasted until 1983. A second Sudanese 
civil war soon developed and ended with the Comprehensive Peace Agreement of 2005. Later 
that year, southern autonomy was restored when an Autonomous Government of Southern 
Sudan was formed. 
South Sudan became an independent state on 9 July 2011, following a referendum that passed 
with 98.83% of the vote. It is a United Nations member state, a member state of the African 
Union, and a member state of the Intergovernmental Authority on Development. In July 2012, 
South Sudan signed the Geneva Conventions 
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Figure 1 South Sudan in map of the world  
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Figure 2 South Sudan in Africa 
 
 
 
 
Figure 3 Sudan and South Sudan 
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Figure 4 map of South Sudan showing the 10 states  
  
  
  
 
Figure 5 Flag of South Sudan 
                                                
 
Motto: "Justice, Liberty, Prosperity"  
Anthem: South Sudan Oyee!  
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 B. SITUATION ANALYSIS 
 1. Political Context 
 
                                 
 
 
 
South Sudan has witnessed perhaps the longest liberation war in modern Africa. The war, 
which began just after independence in August 1955, ended with the signing of the 
Comprehensive Peace Agreement (CPA) in January 2005. The war destroyed physical 
infrastructure and social structures. Over 2.5 million people died while close to 4 million were 
displaced. Consequently, the health system collapsed. During the last phase of the war (1983-
2005), international non-governmental organisations (INGOs) and faith based organisations 
(FBOs) assumed responsibility for basic health service delivery in liberated areas.  However, 
due to insecurity and the vast geographical extent of the country, effective health service 
coverage has remained low at under 25 %. 
 
Following the signing of the CPA, which stipulated an interim period of six years, the 
Government of Southern Sudan (GoSS) was established. This status quo continued until 
January 2011, when the Southern Sudan Referendum on Self-determination was conducted 
and over 98 % of Southern Sudanese voted in favour of secession. On July 9, 2011, South 
Sudan’s independence was proclaimed thus ending more than 190 years of foreign occupation 
and the beginning of a transitional period led by H.E Salva Kiir Mayardit, the first President 
of the Republic of South Sudan.  
 
The country is administratively divided into ten states (Figure 3), which are further sub-
divided into seventy nine counties. The counties are partitioned into 514 smaller 
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administrative units, referred to as Payams.   
 
 2. Demographic and socio-economic situation 
 
The Republic of South Sudan covers a geographical area of approximately 640,000 square 
kilometres. The population is estimated at 8,260,490 million with a density of 15 people per 
square kilometre. More than 90% of the population lives in rural areas.  The average annual 
population growth rate is 2.2%. The population is projected to increase to 12 million by 2015, 
due to both the annual growth rate and the return of South Sudanese from the diaspora, 
following the historic independence of the Republic of South Sudan. Females constitute 52% 
of the population while males account for 48%. The total fertility rate is estimated at 6.7, 
while the average life expectancy at birth for both sexes is 42 years. 
 
South Sudan is endowed with vast natural resources, which include arable 
agricultural land, fresh water, minerals and oil. On the contrary, income per 
capita is extremely low, with about half of the population (50.6%) living on 
less than 1 US$ per day. In addition to high levels of poverty, South Sudan 
has a high disease burden and low levels of education, thus ranking as one 
of the poorest countries in the world. The vast majority of the population is 
engaged in rural subsistence farming and cattle herding. Living conditions 
are associated with poor access to potable drinking water (less than 50%), 
poor access to proper sanitation (less than 7%) and high illiteracy rates 
among the adult population (88% among women and 63% among men). 
 
3. Health status and disease burden  
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South Sudanese people have experienced poor health care provision due to the 
protracted resource and politically motivated conflicts that disrupted the health 
system. Inevitably, this resulted in the country having the worst key health 
indicators globally. 
 
  
 
  
21 
 
Chapter 2 - Overview of HIV/AIDS 
 A. Introduction 
 
HIV stands for human immunodeficiency virus. It is a retrovirus. After getting into the body, 
the virus kills or damages cells of the body's immune system. As the infection progresses, the 
immune system becomes weaker, and the person becomes more susceptible to infections. The body 
tries to accommodate by making new cells or trying to contain the virus, but eventually HIV 
progressively destroys the body's ability to fight infections and certain cancers. 
AIDS stands for acquired immunodeficiency syndrome. It is a collection of symptoms and 
signs of disease. It is the most advanced stage of infection with HIV. It is caused by HIV and 
occurs when the virus has destroyed so much of the body's defenses that immune-cell counts 
fall to critical levels or certain life-threatening infections or cancers develop. It can take 10-15 
years for an HIV-infected person to develop AIDS. 
HIV is transmitted through unprotected sexual intercourse (anal or vaginal), contact with 
contaminated blood or blood products during blood transfusion, sharing of contaminated 
needles, and between a mother and her infant during pregnancy, childbirth and breastfeeding.  
The first signs of HIV infection may be swollen glands and flu-like symptoms. These may 
come and go a month or two after infection. This is typically followed by a prolonged period 
without symptoms called clinical latency. As the illness progressed, it interferes more and 
more with the immune system, making the person much more likely to be infected including 
opportunistic infections and tumors that eventually lead to AIDS. 
HIV can be prevented through safe sex (consistent use of condoms), needle exchange 
programs, and giving Anti-retroviral medications to mothers during pregnancy, childbirth, and 
avoidance of breast milk to infants and children. 
There is no cure or effective vaccine, but anti-retroviral drugs can dramatically slow the  
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progression of the disease and may lead to near normal life expectancy. 
AIDS was discovered in 1981 by the Centers for Disease Control and Prevention (CDC). Its 
cause, HIV infection, was identified two years later, in 1983. Since its discovery, AIDS has 
killed nearly 30 million people as of 2009 and approximately 34 million people have 
contracted HIV globally as of 2010.  
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 B. Global, Regional, and Sub-Saharan Africa HIV and AIDS estimates, 
2009 and 2010  
 1. Global HIV and AIDS estimates, 2009 and 2010  
The latest statistics of the global HIV and AIDS epidemic were published by UNAIDS, WHO 
and UNICEF in November 2011, and refer to the end of 2010.  
 
Table 1 Global HIV/AIDS Estimates 2010 
 
ESTIMATES Range  
People living with HIV/AIDS in 2010  34 million   31.6-35.2    million 
Proportion of adults living with 
HIV/AIDS in 2010 who were women 
(%) 
50 47-53  
Children living with HIV/AIDS in 
2010  
3.4 million   3.0-3.8 million  
People newly infected with HIV in 
2010  
2.7 million   2.4-2.9 million  
Children newly infected with HIV in 
2010  
390,000 340,000-450,000  
AIDS deaths in 2010  1.8 million  1.6-1.9 million  
 
Statistics published by UNAIDS in November 2010, referring to the end of 2009 
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Table 2 Global HIV/AIDS Estimates 2009 
 
 
Estimate  
Range  
People living with HIV/AIDS in 2009  33.3 million  31.4-35.3 million  
Adults living with HIV/AIDS in 
2009                                                         
30.8 million  29.2-32.6 million  
Women living with HIV/AIDS in 2009  15.9 million  14.8-17.2 million  
Children living with HIV/AIDS in 
2009                                                   
2.5 million  1.6-3.4 million  
People newly infected with HIV in 
2009  
2.6 million  2.3-2.8 million  
Adults newly infected with HIV in 
2009  
2.2 million  2.0-2.4 million  
AIDS deaths in 2009  1.8 million  1.6-2.1 million  
Orphans (0-17) due to AIDS in 2009  16.6 million  14.4-18.8 million  
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Figure 6 Global Trends 
 
 
Note: 
The number of people living with HIV rose from around 8 million in 1990 to 34 million 
by the end of 2010. The overall growth of the epidemic has stabilized in recent years. 
The annual number of new HIV infections has steadily declined and due to the 
significant increase in people receiving antiretroviral therapy, the number of AIDS-
related deaths has also declined.  
Since the beginning of the epidemic, nearly 30 million people have died from AIDS-
related causes.  
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  2. Regional statistics for HIV and AIDS, end of 2010  
                                                                                           
 
                                                               
 
  
Table 3 Regional Statistics for HIV/AIDS end of 2010 
Region  
Adults & children 
living with 
HIV/AIDS  
Adults & 
children 
newly infected  
Adult 
prevalence*  
AIDS-related 
deaths in 
adults & children  
Sub-Saharan Africa  22.9 million 1.9 million  5.0%  1.2 million  
North Africa & Middle 
East  
470,000  59,000  0.2%  35,000  
South and South-East Asia 4 million  270,000  0.3%  250,000  
East Asia  790,000  88,000  0.1%  56,000  
Oceania  54,000  3,300  0.3%  1,600  
Latin America 1.5 million  100,000  0.4%  67,000  
Caribbean  200,000  12,000  0.9%  9,000  
Eastern Europe & Central 
Asia  
1.5 million  160,000  0.9%  90,000  
North America 1.3 million  58,000  0.6%  20,000  
Western & Central Europe  840,000  30,000  0.2%  9,900  
Global Total  34 million  2.7 million  0.8%  1.8 million  
 
* Proportion of adults aged 15-49 who are living with HIV/AIDS 
With around 68 percent of all people living with HIV residing in sub-Saharan Africa, the 
region carries the greatest burden of the epidemic. Epidemics in Asia have remained relatively 
stable and are still largely concentrated among high-risk groups. Conversely, the number of 
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people living with HIV in Eastern Europe and Central Asia has more than tripled since 2000. 
  
Adults are defined as men and women aged 15 or above, unless specified otherwise. Children 
orphaned by AIDS are defined as people aged under 18 who are alive and have lost one or 
both parents to AIDS.  
All the statistics presented in table 3 should be interpreted with caution because they are 
estimates. 
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 3. Sub-Saharan Africa HIV & AIDS Statistics 
  
In 2010 there were an estimated 22.9 million people living with HIV in Sub-Saharan Africa. 
This has increased since 2009, when an estimated 22.5 million people were living with HIV, 
including 2.3 million children.  
The increase in people living with HIV could be partly due to a decrease in AIDS-related 
deaths in the region. There were 1.2 million deaths due to AIDS in 2010 compared to 1.3 
million in 2009. Almost 90% of the 16.6 million children orphaned by AIDS live in sub-
Saharan Africa.  
The latest figures for each sub-Saharan African country showing the number of people living 
with HIV, the number of deaths from AIDS, and the number of living orphans were published 
in 2010 and refer to 2009. They are shown below.  
Table 4 Sub-Saharan Africa Statistics, 2009, the greatest burden nations 
Country  
People 
living with 
HIV/AIDS 
Adult (15-
49) 
prevalence 
%  
Women 
with 
HIV/AIDS  
Children 
with 
HIV/AIDS  
AIDS 
deaths  
Orphans 
due to 
AIDS  
South Africa 5,600,000 17.8 3,300,000 330,000 310,000 1,900,000 
Nigeria 3,300,000 3.6 1,700,000 360,000 220,000 2,500,000 
Kenya 1,500,000 6.3 760,000 180,000 80,000 1,200,000 
Tanzania 1,400,000 5.6 730,000 160,000 86,000 1,100,000 
Mozambique 1,400,000 11.5 760,000 130,000 74,000 670,000 
Uganda 1,200,000 6.5 610,000 150,000 64,000 1,200,000 
Zimbabwe 1,200,000 14.3 620,000 150,000 83,000 1,000,000 
Zambia 980,000 13.5 490,000 120,000 45,000 690,000 
Malawi 920,000 11 470,000 120,000 51,000 650,000 
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Table 5 All sub-Saharan Africa nations 
Country  
People living 
with 
HIV/AIDS 
Adult (15-49) 
prevalence %  
Women with 
HIV/AIDS  
Children 
with 
HIV/AIDS  
AIDS 
deaths  
Orphans 
due to 
AIDS  
Angola  200,000  2.0  110,000  22,000  11,000  140,000  
Benin  60,000  1.2  32,000  5,400  2,700  30,000  
Botswana  320,000  24.8  170,000  16,000  5,800  93,000  
Burkina Faso  110,000  1.2  56,000  17,000  7,100  140,000  
Burundi  180,000  3.3  90,000  28,000  15,000  200,000  
Cameroon  610,000  5.3  320,000  54,000  37,000  330,000  
Central African 
Republic  
130,000  4.7 67,000  17,000  11,000  140,000  
Chad  210,000  3.4  110,000  23,000  11,000  120,000  
Comoros  <500  0.1  <100  ...  <100  <100 
Congo  77,000  3.4  40,000  7,900  5,100  51,000  
Côte d'Ivoire  450,000  3.4  220,000  63,000  36,000  440,000  
Dem. Republic 
of Congo  
(430,000- 
560,000)  
(1.2- 
1.6)  
(220,000- 
300,000)  
(33,000- 
86,000) 
(26,000- 
40,000) 
(350,000- 
510,000) 
Equatorial 
Guinea 
20,000  5.0  11,000  1,600  <1,000  4,100  
Eritrea  25,000  0.8  13,000  3,100  1,700  19,000  
Gabon  46,000  5.2  25,000  3,200  2,400  18,000  
Gambia  18,000  2.0  9,700  ...  <1,000  2,800  
Ghana  260,000  1.8  140,000  27,000  18,000  160,000  
Guinea  79,000  1.3  41,000  9,000  4,700  59,000  
Guinea-Bissau  22,000  2.5  12,000  2,100  1,200  9,700  
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Kenya  1,500,000  6.3  760,000 180,000 80,000  1,200,000  
Lesotho  290,000  23.6  160,000  28,000  14,000  130,000  
Liberia  37,000  1.5  19,000  6,100  3,600  52,000  
Madagascar  24,000  0.2  7,300  ... 1,700  11,000  
Malawi  920,000  11.0  470,000  120,000  51,000  650,000  
Mali  76,000  1.0  40,000  ... 4,400  59,000  
Mauritania  14,000  0.7  4,000  ... <1,000  3,600  
Mauritius  8,800  1.0  2,500  ... <500  <1,000  
Mozambique  1,400,000  11.5  760,000  130,000  74,000  670,000  
Namibia  180,000  13.1  95,000  16,000  6,700  70,000  
Niger  61,000  0.8  28,000  ... 4,300  57,000  
Nigeria  3,300,000  3.6  1,700,000  360,000  220,000  2,500,000  
Rwanda  170,000  2.9  88,000  22,000  4,100  130,000  
Senegal  59,000  0.9  32,000  ... 2,600  19,000  
Sierra Leone 49,000  1.6  28,000  2,900  2,800  15,000  
South Africa  5,600,000  17.8  3,300,000  330,000  310,000  1,900,000  
Swaziland  180,000  25.9  100,000  14,000  7,000  69,000  
Togo  120,000  3.2  67,000  11,000  7,700  66,000  
Uganda  1,200,000  6.5  610,000  150,000  64,000  1,200,000  
United Rep. Of 
Tanzania  
1,400,000  5.6  730,000  160,000  86,000  1,100,000  
Zambia  980,000  13.5  490,000  120,000  45,000  690,000  
Zimbabwe  1,200,000  14.3  620,000  150,000  83,000  1,000,000  
Total sub-
Saharan Africa  
22,500,000  5.0  12,100,000  2,300,000  1,300,000  14,800,000  
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Note  
These estimates include all people with HIV infection, including those who have not 
developed symptoms of AIDS.  
Adults in this page are defined as men and women aged over 15, unless specified 
otherwise.  
Children are defined as people under the age of 15, whilst orphans are children aged 
under 18 who have lost one or both parents to AIDS.  
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Chapter 3 - HIV/AIDS- Prevalence, Risk Factors, and 
Transmission in South Sudan  
 
 
  
 A. BACKGROUND 
 
Based on available antenatal surveillance data (2009), South Sudan has a generalized low HIV 
epidemic with a prevalence rate of 3% among the adult population. UNAIDS South Sudan 
HIV /AIDS estimates put the number individuals living with HIV in 2012 at 151996 adults 
and children. Recent MOH behavioral and sero-prevalence studies indicate high risk 
behaviors’ among young people, the military and among PLWHA and low condom use 
suggesting that the epidemic could rapidly increase and reach as highly as nearly 6% by 2015, 
unless current interventions are scaled-up and sustained. Geographic disparities exist between 
urban and rural areas and also across states: Juba 6 percent; highest estimates in Western 
Equatoria at 7.2 percent and lowest in rural areas at 1 percent. The 2010 household survey 
data show that only 53 percent of women 15-49 years old have ever heard of HIV or AIDS, 
and only 19.3 percent know of a place to get tested.  In addition, only 15 percent of women 
who give birth two years prior to the study and had access to ANC services received HIV 
counseling and testing, while only 9 percent of these women were tested for HIV while 
seeking antenatal care. 
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Table 6 Projected adult HIV prevalence, new infections and PLWHA in need of ART and 
PMTCT services in South Sudan. 
Year 2005 2006 2007 2008 2009 2010 2011 2012 2013 
HIV Adults + 
Children 119359 124555 129513 134236 138687 143048 147284 151996 157315 
HIV Adults 15+ 108553 112730 116679 120432 123993 127558 131103 135283 140217 
HIV population- 
Children 10806 11825 12834 13804 14694 15490 16182 16712 17098 
Prevalence Adult 2.99 3.03 3.05 3.06 3.06 3.06 3.05 3.06 3.08 
New HIV 
infections- Adult 12157 12044 12076 12260 12539 12758 13064 13316 13200 
New HIV 
infections- 
Children 2558 2639 2703 2751 2773 2767 2731 2613 2476 
Need for ART- 
Adult (15+) 16350 18286 20165 21927 23546 25066 26693 49515 52176 
 
  
Table 7 HIV/AIDS Estimates in South Sudan, 2011   
Number of people living with HIV                      150,000 [100,000 - 200,000] 
Adults aged 15 to 49 prevalence rate 3.10% [2.10% - 4.20%] 
Adults aged 15 and up living with HIV 130,000 [88,000 - 180,000] 
Women aged 15 and up living with HIV 77,000 [52,000 - 100,000] 
Children aged 0 to 14 living with HIV 16,000 [11,000 - 23,000] 
Deaths due to AIDS 11,000 [7,500 - 16,000] 
Orphans due to AIDS aged 0 to 17 N/A 
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 B. Risk Factors that may be contributing to continuing HIV incidence in 
South Sudan 
 
 
The southern Sudan HIV epidemic and response review report (SSAC 2011) gives a summary of 
findings of two recent behavioral studies, the Household Health Survey 2010 (HHS) and the 
Kajo Keji County Behavioral Survey 2009 (KKBSS), demonstrating that there are several 
biological and behavioral factors that may be contributing to continuing HIV incidence in South 
Sudan. These include; 
 A high rate of sexually transmitted infections (STIs)  
 Most men in Southern Sudan who are not Muslim are not circumcised  
 Early age of first sex and a low level use of condoms 
 Multiple sexual partners 
 A low level of knowledge in both men and women about the means of transmission of 
HIV and how to protect themselves 
 A high level of stigma and discrimination against people who might be HIV-positive 
 
 
 C. Transmission of HIV/AIDS  
 
 
In general, HIV is transmitted by three main routes; sexual contact, exposure to infected body 
fluids, tissues, or organs and from mother to child during pregnancy, childbirth or breastfeeding 
(vertical transmission). 
Most commonly, HIV infection is spread by having sex (vaginal, anal, or oral) with an infected 
partner. The virus can enter the body through the lining of the vagina, vulva, penis, rectum, or 
mouth during sex. 
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Women can transmit HIV to their babies during pregnancy or birth, when infected maternal cells 
enter the baby's circulation, or through breastfeeding. 
HIV frequently spreads among injection-drug users who share needles or syringes that are 
contaminated with blood from an infected person. 
HIV can be spread in health-care settings through accidental needle sticks or contact with 
contaminated fluids such as amniotic, synovial, or cerebro-spinal fluids. 
HIV can be transmitted through transfusion of contaminated blood or blood components. This 
still happening in developing countries, but is very rarely in developed nations where blood and 
blood products are screened before used. Similarly, if tissues or organs from an infected person 
are transplanted, the recipient may acquire HIV. Donors are now tested for HIV to minimize this 
risk. 
 
 
 
 
 
 
 
 
 
 
 
 
36 
 
Chapter 4 - Management, Treatment, Care and Support of 
HIV/AIDS individuals in South Sudan  
 
                                                            
 A. General Management of HIV/AIDS 
 
Currently, no cure or effective HIV/AIDS vaccine, but treatment consists of high active 
antiretroviral therapy (HAART) which slows progression of the disease. Treatment also includes 
preventative and active treatment of opportunistic infections and certain cancers, post-exposure 
prophylaxis, as well as complementary/alternative medicine and healthy lifestyle and home 
remedies. 
 
 1. Anti-retroviral therapy 
 
 
Figure 7 Abacavir – a nucleoside analog reverse transcriptase inhibitor (NARTI or NRTI) 
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It is recommended to take at least three different anti-retrovirals (ARVs, or HAART) from two 
different classes to avoid creating strains of HIV that are immune to single drugs.   
The classes of anti-HIV drugs include: 
 
 Non-nucleoside reverse transcriptase inhibitors (NNRTIs). NNRTIs disable a protein 
needed by HIV to make copies of itself. Examples include efavirenz (Sustiva), etravirine 
(Intelence) and nevirapine (Viramune). 
 Nucleoside reverse transcriptase inhibitors (NRTIs). NRTIs are faulty versions of 
building blocks that HIV needs to make copies of itself. Examples include Abacavir 
(Ziagen), and the combination drugs emtricitabine and tenofovir (Truvada), and 
lamivudine and zidovudine (Combivir). 
 Protease inhibitors (PIs). PIs disable protease, another protein that HIV needs to make 
copies of itself. Examples include atazanavir (Reyataz), darunavir (Prezista), 
fosamprenavir (Lexiva) and ritonavir (Norvir). 
 Entry or fusion inhibitors. These drugs block HIV's entry into CD4 cells. Examples 
include enfuvirtide (Fuzeon) and maraviroc (Selzentry). 
 Integrase inhibitors. Raltegravir (Isentress) works by disabling integrase, a protein that 
HIV uses to insert its genetic material into CD4 cells. 
Current guidelines indicate that treatment should begin if:  
 You have severe symptoms 
 Your CD4 count is under 500 
 You're pregnant 
 You have HIV-related kidney disease 
 You're being treated for hepatitis B 
Treatment with anti-retrovirals often improves current, as well as decreases the risk of future, 
opportunistic infections. However, vaccination against Hepatitis A and B is advised before and 
after infection with HIV. Prevention and treatment of Tuberculosis, provision of 
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Trimethoprim/Sulfamethoxazole prophylaxis, prevention of pneumocystis carini pneumonia, and 
prophylaxis for Toxoplasmosis and Cryptococcal meningitis for people with substantial 
immunosuppression are also advised. 
 
 2. Post-exposure Prophylaxis 
 
Post-exposure prophylaxis (PEP) involves taking anti-HIV drugs as soon as possible after you 
may have been exposed to HIV to try to reduce the chance of becoming HIV positive. There are 
two types of PEP: (1) occupational PEP, (sometimes called "oPEP"), and (2) non-occupational 
PEP, (sometimes called “nPEP”).   
Workplace exposure (oPEP) is when someone working in a health-care setting is potentially 
exposed to material infected with HIVsuch as needle sticks or cuts, getting blood or other body 
fluids in their eyes or mouth, getting blood or other body fluids on their skin when it is chapped, 
scraped, or affected by dermatitis 
Non-occupational exposure (nPEP) is when someone is potentially exposed to HIV outside the 
workplace (e.g., condom breakage, sexual assault, etc.) 
To be effective, PEP must begin within 72 hours of exposure, before the virus has time to rapidly 
replicate in your body. PEP consists of 2-3 antiretroviral medications and should be taken for 28 
days. Your doctor will determine what treatment is right for you based on how you were exposed 
to HIV. The medications have serious side effects that can make it difficult to finish the program. 
PEP is not 100% effective; it does not guarantee that someone exposed to HIV will not become 
infected with HIV. 
 3. Healthy Lifestyle 
 
While medicines are a must for treating HIV, they are only one part of living a healthy life. A 
good diet, daily exercise, plenty of rest, and going to all of your medical appointments are all 
part of a healthy life. 
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 B. Strategies use for Treatment, Care and Support for HIV/AIDS individuals 
in South Sudan 
 
 
One of the major objectives of the Ministry of Health is to provide greater care, support and 
treatment to the larger number of PLHIV in South Sudan, with ultimate goal of universal access 
for all those who need it. The Care, Support and Treatment component of the HIV/AIDS 
Division aims to provide comprehensive management to PLWHA with respect to prevention and 
treatment of Opportunistic Infections including TB, Anti-retroviral Therapy (ART), psychosocial 
support, home-based care, positive prevention and impact mitigation. 
 
Anti-retroviral Therapy (ART) for eligible persons living with HIV/AIDS was launched 
in 2004 in three hospitals. Since then, the programme has been scaled up both in terms of 
facilities for treatment to 22 and number of beneficiaries seeking ART. The Main services 
provided to PLWHA under care, support and treatment include: 
 Registration of PLWHA for ART and pre-ART services; 
 Assessment of eligibility of ART based on clinical examination and CD4 count;  
 Provision of first line ART to all eligible PLWHA and CLHA 
 Follow-up of patients on ART by assessing drug adherence, regularity of visits and 
periodic examination and CD4 count (every 6 months) 
 Care, support and home-based services 
 Treatment of opportunistic infections; and 
 Provision of alternate first line and second-line ART to those experiencing drug toxicities 
and treatment failure, respectively 
 
40 
 
  Program Results 
 
 1. Activities undertaken in 2011 
 
1. The HIV/AIDS/STI Division in the Directorate of Community and Public Health, 
Ministry of Health – Republic of South Sudan (MOH-RoSS) in collaboration with UNDP 
organized and conducted  a seven days training for the Health Care Providers on the 
Management of HIV/AIDS in pediatrics. The training took place in Yei town at Crop 
Training Center from 8 - 15, Aug. 2011. This training was done among the ART site 
clinicians for the first time in the Republic of South Sudan. The participants were those 
who had already been trained in Integrated Management of Adolescent and Adult Illness 
(IMAI) and were still practicing in the ART facilities. A total of 27 participants attended 
the training from all over 10 States of South Sudan. The learning Objectives were: 
a) Explain briefly and in basic terms what HIV is and how it is transmitted to Infants 
and children. Describe how to assess and classify a child for HIV/AIDS. Describe 
how to assess, classify and treat acute common illnesses in young infants and 
children classified for HIV/AIDS. 
b) Describe how to assess, classify and treat common opportunistic infections in 
infants and young children classified for HIV/AIDS, with a focus on skin and 
mouth conditions. 
c) Describe how to prevent common illnesses in infants and young children 
classified for HIV, describe how to effectively communicate with the HIV 
positive mother. 
d) Describe different feeding options and the processes involved in counseling the 
HIV positive mother about feeding. Describe how you would follow up children 
born to HIV positive women, and be able to differentiate between: 
e) Follow up of children classified as HIV exposed 
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f) Chronic care for children with suspected symptomatic HIV or confirmed HIV 
infection 
 
2. The Division of HIV/AIDS staff conducted Supportive supervision visits to health 
facilities providing ART in three states (Eastern and Western Equatoria and Western 
Bahr El Ghazal) of South Sudan. The objectives of the visits included; 
 Visit the ART, PMTCT, VCT clinics to evaluate HIV related activities 
 Provide clinical mentorship to the ART team 
 Meet with the ART staff members to provide feedback of the visit 
 Meet with the hospital director to debrief on the visit findings and 
recommendations 
The methodology used in the supportive supervision visits comprised of interviews with 
health workers, data verification/validation and observation of service provision. 
  
Figure 8 Division of HIV/AIDS staff verify ART Registers and monthly ART report data at 
Torit State Hospital  
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 2. Some of the challenges facing the ART sites; 
 
 ARV and other medicine runs out which leads to patients dropping from treatment 
 Limited availability of  stock cards, poor knowledge of filling the stock cards and how to 
place orders  
 Poor quality of medical care due to unavailability of medicines most of the time. 
 New patients are not thoroughly examined for proper staging 
 Weak home based care and support to HIV patients. Health workers have problems 
accessing patients at home due to poor means of transport 
 Lack of power supply to the facility can contribute to poor storage conditions of test kits 
that need cold temperature. 
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 Inadequate space in the labs for installing required equipment 
 Inadequate training in operating CD4 machines 
 There is poor recording of registers, compilation of monthly reports and weak reporting 
system at most of ART sites in South Sudan which leads non reporting, delayed reports 
or inaccurate reports being sent to the HIV/AIDS/STIs division in the MOH. 
 Limited provision of maintenance services to the CD4 and Hum count machine is always 
a problem because the agents for the manufacturers are not based in South Sudan.  
 Drug distribution to some facilities in-time remains a big challenge  
 
 3. Recommendations from the Supportive Supervision visits include; 
 
 Drug exchange (e.g. CTX) based on need  among the different ART facilities in the state 
to reduce cases of out-stocked and over-stocked 
 Supply chain management refresher training for the store keepers and dispensers 
 Proper arrangement for drug delivery to the health facilities 
 The current services provision to both CD4 and Humacount machines should be 
reconsidered 
 Regular supportive supervision of a joint team between the MOH,UNDP and WHO 
should be organized for a good technical support on the ground 
 Monitoring of the initial enrollment of HIV clients into either  care or on ART according 
to STGs   
 Strong counseling on adherence to treatment, care and support should be improved 
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  4. Number of sites 
 
     
 In 2011/2012, 7 new facilities started offering HIV Care and treatment services in South 
Sudan. This brings the total number of facilities offering HCT services to 22 as figure 10 
shows. All these facilities are located in all the ten states of South Sudan and receive support 
from the Ministry of health, Global Fund and WHO. 
 
                                                                                                 
Figure 9 Number of ART Sites 2006-2011 
 
 
 
 5. Number of adults and children ever enrolled on HIV Care and ART 
 
As figure 11 below shows majority of patients ever enrolled for HIV Care (17441) and ART 
(6522) are adults. Only about 774 and 190 children have ever been enrolled for HIV Care and 
ART respectively. This shows the need to put more children on HIV Care and ART. 
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Figure 10 Number of HIV Patients ever enrolled for HIV Care and ART by age, March 
2012 
 
 6. Number of individuals currently on ART 
 
Adherence to ART is an essential component of individual and programmatic treatment success. 
Higher levels of adherence are associated with improved virological and clinical outcomes. Rates 
of adherence exceeding 95% are desirable in order to maximize the benefits of ART. This means 
taking the correct dose of drugs at the correct times while observing any dietary restrictions 
 
As of March 2012, there were 4134 individuals currently on ART. As figure 12 below shows 
this is a great improvement from 1258 the number currently on ART 2008. However, this 
number does not compare well with the total number of individuals (6712) ever enrolled on 
ART. This means that about 39 percent have either died, lost to follow up or did not pick their 
drugs. 
 
 
 Figure 11 Number of individuals currently on ART, 2008-2012 
46 
 
 
 
 
 
 7. Number of individuals currently on Cotrimoxazole Prophylaxis 
 
According to the Ministry of Health guidelines for the use of Antiretroviral drugs in adults and 
children, all HIV-infected individuals, regardless of age, treatment or immunological status, 
should be given Cotrimoxazole unless contraindicated. Studies have suggested Cotrimoxazole 
is effective against common causes of death and risks of disease including malaria in people 
with HIV regardless of whether they are on ART or not. 
 
Contraindications include allergy to Cotrimoxazole which commonly manifests as a rash that 
can be severe and progress to Stevens Johnson Syndrome. This recommendation is in line with 
the 2006 WHO guidelines for use of Cotrimoxazole prophylaxis in resource-limited settings 
where bacterial infections and malaria are prevalent and cause significant morbidity across a 
wide immunological spectrum in PLWHA. 
 
Approximately 7600 patients received Cotrimoxazole in the month of March 2012 in all the 
HIV Care and ART facilities that reported. This figure can be used as a proxy for estimating 
the number of HIV positive individuals currently on HIV care. This includes the number of 
patients on ART 
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 8. Standardized Antiretroviral Drug Regimens 
 
The Ministry of Health, Republic of South Sudan has decided on standardized antiretroviral 
drug regimens in line with the revised (2006) WHO Guidelines on ART in resource limited 
settings. The choice of regimens reflects the imperatives of a public health approach to scaling 
up of ART. Further, the regimens chosen have been selected with efficacy, tolerability and 
opportunities for second line treatment in mind. 
 
 
 
 
 
Table 8 Number of Patients on 1st Line ARV Regimen by sex and age, March 2012 
On 1st line regimen Male Female Total 
Adults (>14 years) 
   ZDV-3TC-EFV  244 320 564 
ZDV-3TC-NVP  708 1728 2436 
d4T-3TC-EFV 16 16 32 
d4T-3TC-NVP 304 643 947 
TFV-3TC-EFV  3 1 4 
TFV-3TC-NVP  2 2 4 
ABC-3TC-EFV  0 0 0 
ABC-3TC-NVP  0 0 0 
Children (0-14 years) 
   ZDV-3TC-EFV  8 6 14 
ZDV-3TC-NVP  56 36 92 
d4T-3TC-EFV 0 0 0 
d4T-3TC-NVP 25 16 41 
 
 
 9. Pediatric HIV Care and ART 
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Most children acquire HIV infection in-utero, during delivery or through breastfeeding. 
Thus, the most efficient and cost-effective way to tackle pediatric HIV is to reduce mother-to-
child transmission. However, every day there are new infections in children under 15 years of 
age and most being associated with Mother-To-Child Transmission.  
 
HIV-infected infants frequently present with clinical symptoms in the first year of life, and by 
one year of age an estimated one-third of infected infants will have died, and about half by 2 
years of age. There is thus a critical need to provide antiretroviral therapy (ART) for infants 
and children who become infected despite the efforts being made to prevent such infections. 
 
As figures 13 below show there are very few children enrolled both on HIV Care and ART in 
South Sudan 
                                                                  
Figure 12 Individuals ever enrolled for 
HIV Care and ART by age, 2011 
 
 
 
 
 
 
 
As figure 14 below shows majority of children on ART are aged between 5 and 14 years. Only 
about 2 percent are aged less than 1 year. 61 percent and 28 percent are on ZDV-3TC-NVP and 
d4T-3TC-NVP respectively. 
 
 
49 
 
Figure 13 % of PEADs by age 
 
 
 
 
Figure 14 % of PEADs by 1st line 
regimen 
 
 
 
 
 10. TB - Screening and Treatment at ART Sites 
 
 
Tuberculosis (TB) is a significant cause of morbidity and mortality in HIV-infected patients. 
The risk of developing tuberculosis (TB) is estimated to be between 20-37 times greater in 
people living with HIV than among those without HIV infection.  
 
The Three I’s for HIV/TB (Intensified case finding for TB, Isoniazid preventive therapy, and 
Infection control) reduces the burden of TB among people living with HIV and therefore must 
be urgently implemented by all HIV services. People living with HIV need early diagnosis and 
treatment of active TB disease. If TB is not present, they should receive Isoniazid preventive 
therapy (IPT). The treatment should be free of charge and is not expensive for the health 
system. 
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Table 9 TB Screening and treatment at ART Sites, 2011 
  Male Female Total 
  PreART ART PreART ART PreART ART Total 
Number TB Screened, found with 
no signs of TB 610 620 1361 1419 1668 1905 4010 
On INH prophylaxis 0 0 0 0 0 0 0 
Sputum: TB suspect Sputum 
sample taken  15 17 12 12 27 29 56 
TB Refer: TB suspect referred for 
investigation 12 5 23 13 14 5 53 
TB Rx: On TB treatment during 
the month 17 30 15 29 32 58 91 
TOTAL whose TB status was 
assessed at last visit during the 
reporting period 654 671 1419 1468 1750 1991 4312 
 
Isoniazid (INH) is an anti-tuberculosis medication which when taken regularly can 
significantly reduce the rate of later development of active TB disease. As table 8 above shows 
no TB/HIV patients were on INH prophylaxis in South Sudan for 2011. 
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Chapter 5 - Measures for Prevention and Control of HIV/AIDS 
in General and in South Sudan 
 
                                                               
 A. Overview of Measures for Prevention and Control of HIV/AIDS 
 
 Social strategies 
These strategies require people to change their behaviors in order to avoid contracting HIV. 
These include sex education, LGBT sex education, needle-exchange programs, safe injection 
sites, safe sex, serosorting, sexual abstinence, immigration regulation. 
 Sexual contact 
Consistent and proper use of a new condom in every sex act (anal, vaginal) reduces the risk of 
HIV transmission by approximately 80% over the long-term. Where one partner of a couple is 
infected, consistent condom use results in risk of HIV infection for the uninfected person of 
below 1% per year. During oral sex use a condom, dental dam — a piece of medical-grade 
latex — or plastic wrap. Condoms are a universally medically proven method for preventing 
the spread of HIV during sexual intercourse. They are also the only method promoted by health 
authorities worldwide. Similarly, women can consider female condoms and vaginal gel as well. 
In sub-Saharan Africa, both World Health Organization and UNAIDS recommended male 
circumcision as a method of reducing female-to-male HIV transmission in 2007. There is 
evidence that male circumcision reduces the risk of HIV infection in heterosexual men by 
between 38% and 66% over two years. 
Abstain from sex. This obviously has limited appeal, but it absolutely protects against HIV 
transmission by this route. 
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Comprehensive sexual education provided at school may decrease high risk behavior. 
 
 Mother-to-child 
The risk of HIV transmission from a pregnant woman to her baby is significantly reduced if the 
mother takes medications during pregnancy, labor, and delivery and her baby is given 
medications (ARVs) for the first six weeks of life. The key is to get tested for HIV as early as 
possible in pregnancy. In consultation with their physician, many women opt to avoid 
breastfeeding to minimize the risk of transmission of HIV after delivery. Sometimes, elective 
caesarian sections are considered. 
 Pre-exposure prophylaxis (PrEP) 
This is a new HIV prevention method in which people that do not have HIV take a daily pill to 
reduce their risk of becoming infected. When used consistently, PrEP has been shown to be 
effective in men who have sex with men (MSM), sero-discordant couples, and heterosexually-
active men and women.  
Based on studies to date, in July 2012 the U.S. Food and Drug Administration approved the 
combination medication tenofovir disoproxil fumarate plus emtricitabine (TDF/FTC) for use as 
PrEP among sexually active adults at risk for HIV infection.  
Those who work in a health-care field should follow recommended guidelines for protecting 
themselves against needle sticks and exposure to contaminated fluids. 
Harm reduction strategies such as needle/syringe exchange programs are effective in 
preventing HIV among intravenous drug users (IDUs) and broader community. 
Pharmacy sales of syringes and physician prescription of syringes have been also found to 
reduce HIV risk. Supervised injection facilities are also understood to address HIV risk in the 
most-at-risk populations.   
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 Post-exposure prophylaxis (PEP)  
Post-exposure prophylaxis is the use of ARVs as soon as possible after exposure to HIV, to 
prevent HIV infection. These medications are only available with a prescription. PEP should 
begin as soon as possible after exposure to HIV but certainly within 72 hours. Treatment with 2 
or 3 ARVs should continue for 4 weeks, if tolerated. 
PEP has been standard procedure since 1996 for healthcare workers exposed to HIV. Workers 
start taking medications within a few hours of exposure. Usually the exposure is from a 
“needle stick,” when a health care worker accidentally gets jabbed with a needle containing 
HIV-infected blood. PEP reduced the rate of HIV infection from workplace exposures by 79%. 
However, it is still possible for health care workers who take PEP to get HIV infection. 
 
In 2005, the Centers for Disease Control reviewed information on PEP. They concluded that it 
should also be available for use after HIV exposures that are not work-related. People can be 
exposed to HIV during unsafe sexual activity, when a condom breaks during sex, or after 
sexual assault, or if they share needles for injecting drugs. Infants can be exposed if they drink 
breast milk from an infected woman. In a study of PEP in 400 cases of possible sexual 
exposure to HIV, not one person became infected with HIV. 
Current treatment regimens typical use lopinavir/ritonavir and lamivudine/zidovudine or 
emtricitabine/tenofovir and may decrease the risk further. 
 
 7. Vaccination 
As of 2012 there is no effective vaccine for HIV or AIDS. A single trial of the vaccine RV 144 
published in 2009 found a partial efficacy rate of ~30% and has stimulated optimism in the 
research community regarding developing a truly effective vaccine. Further trials of the 
vaccine are ongoing.  
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                      B. Measures for Prevention and Control of HIV/AIDS in South 
Sudan 
        
 
Mother to child transmission (MTCT) is by far the most significant way of spreading of HIV 
infection to children under the age of 15 years. This occurs during pregnancy, childbirth, or 
breastfeeding. AIDS threatens to worsen child survival in South Sudan, which has one of the 
worst infant mortality rates in the world. 
The Ministry of Health (M.o.H), Republic of South Sudan, uses the WHO/UNICEF/UNAIDS 
strategies to minimize MTCT of HIV: 
 Primary prevention of HIV among parents. 
 Prevention of unwanted pregnancy among HIV positives. 
 Prevention of HIV transmission from HIV infected females to their infants through 
ARVs to pregnant females (reduce maternal viral load with ARVs drug). 
 Prevention of avoidable exposure to maternal virus at birth through improved obstetric 
practices (strict application of infection prevention precautions, and where applicable, 
caesarian section) and reduction of exposure to HIV through breast feeding or 
replacement feeding for infants. 
 Provide appropriate treatment, care and support for women living with HIV, their 
children and families. 
 
The guiding principles of the PMTCT program include; 
 Integration: PMTCT service must be integrated into all maternal newborn and child 
health, antiretroviral therapy, family planning and sexually transmitted infection 
services. 
 Equity: Access to services must be equitable, with prioritization or scale up of PMTCT 
services to the most affected, higher prevalence communities. 
 Standardization: Women and children attending maternal, newborn and child health 
services should be provided with an integrated package of services. 
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 Human Right, Confidentiality, Voluntary Informed Consent, Community 
Participation and Mobilization, and Family Centered Care: Identifying women 
living with HIV in PMTCT programs should be used as an entry point to recommend 
HIV testing and counseling to other family members. 
 Involvement of People Living With HIV/AIDS (PLWHA): The participation of 
peers, especially women living with HIV. 
 Partner involvement in Prevention of Mother to Child Transmission (PMTCT): 
PMTCT interventions should be based on the principle that both mother and father have 
an impact on HIV transmission to the infant. 
 
 Prevention of Mother to Child Transmission (PMTCT) Programs: 
 
 1. Activities undertaken 
 
 The Ministry of Health in collaboration with International HIV/AIDS Alliance, 
UNICEF, conducted a training workshop for health care providers on PMTCT in YEI, 
from 7-12 November 2001, 14 participants were trained; in TORIT, 18 participants 
were trained, in MALAKAL, from 15-22
nd
 August 2011, 21 health care providers were 
trained using South Sudan PMTCT training manual. 
 Distribution of PMTCT data collection and reporting tools. 
 Supportive supervision to facilities. During the period under review three supportive 
supervision visits were conducted to the sites. The aims of the supervision visits 
included offering programmatic support to the sites, on job training and mentoring and 
data verification. The following sites were visited YEI Civil Hospital, St. Bakhita 
PHCC, St Martha PHCC, YEI SPLA VCT, Lasu PHCC, Ombasi, Kay PHCC, Wodabi. 
 With support from Health Net TPO the Ministry of health conducted TOT training on 
PMTCT in Wau from June 12-23. 8 participants drawn from Unity, Western Bahr el 
Ghazel, Northern Bahr el Ghazel and Warrap states were trained.   
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 In collaboration with MSH the Ministry of health conducted PMCT refresher training 
in Juba from the 26
 
- 31 March 2012. The 12 participants were drawn from Western 
Bahr el Ghazel, Upper Nile, and Central Equatoria states. The participants included 
Midwives, Nurses, VCT counselors, and community health workers. 
 
 2. Number of sites 
 
In 2011, a total of 25 facilities started offering PMTCT services in South Sudan. This brings 
the total number of facilities offering PMTCT services to 65 sites. All these facilities are 
located in all the ten states of South Sudan and receive support from the Ministry of health and 
partners including; Global Fund, UNICEF and PEPFAR.  
 
 3. Counseling and Testing at PMTCT sites 
 
In 2011, the number of pregnant women counseled and tested at ANC, Maternity and Post 
Natal care as figure 15 below shows were 34875, from a low of 3089 pregnant women in 2008. 
This is a tenfold achievement since the PMTCT services were started in South Sudan in 2008. 
This brings to a total of 84185 pregnant women tested at PMTCT sites since 2008. 
 
 
Figure 15 Number of women counseled and tested at PMTCT sites, South Sudan 2008 - 
2011 
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 4. Provision of PMTCT Services in Various States 
 
As figure 18 below on testing for HIV at PMTCT for Global fund supported sites shows, more 
pregnant women were tested in 2010 than in 2011. The reason for this is an acute shortage of 
HIV test kits towards the end of year. The data also reveals that majority of the pregnant 
women tested in 2010 and 2011 were in Central Equatorial State, Jonglei and Western Bar El-
Ghazal. Whereas, states such as Eastern Equatorial State, Unity, Warrap and Northern Bar El-
Ghazal reported the least pregnant women tested at PMTCT sites. 
 
Figure 16 Number of Pregnant women tested for HIV at PMTCT sites supported by 
Global fund by States 
 
 
 
5. HIV Testing uptake at PMTCT 
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The number of pregnant women tested for HIV at PMTCT sites increased from 33098 in 2010 
to 34857 in 2011. However, PMTCT uptake at first ANC declined in 2011 when compared to 
2010 as figure 17 below shows. 
 
Figure 17 uptake of PMTCT Services at 1st ANC Visit, 2010 - 2011 
 
Note: 
In 2011, a total of 1037 pregnant women tested positive for HIV in all the PMTCT sites. 
Eighty eight percent (88%) of these were given antiretroviral for preventing mother to child 
transmission of HIV.   
 
 6. Challenges faced this Year 
 
 Running out of HIV Test kits 
 Inadequate qualified staff 
 Inadequate funding for training and other programmatic activities 
 Inappropriate selection of PMTCT training participants with inadequate or little 
educational back ground 
 For refreshers and TOT training some of participants did not go under the basic training 
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 7. Planned activities for the next year: 
 Establish 5 new PMTCT sites  
 Training of 200 health care providers on PMTCT 
 Training of 280 health care professional on HBC 
 
 8. Ways forward  
 To improve on Criteria for selecting participants for PMTCT training  
 
 2. HIV Counseling and Testing 
 
In South Sudan, HIV testing is done at both VCT sites where a person is counseled and tested 
for HIV on his/her own volition (Client Initiated) or at PITC sites (Provider Initiated), where 
one is advised by a health service provider on the need to take a HIV test.  
 
These sites are the entry points for reinforcing HIV prevention messages and linking the HIV 
positive people to HIV care, support and treatment services. When conducting counseling and 
testing services, people access accurate information about HIV prevention and care, and 
undergo an HIV test in a supportive and confidential environment. People who are found to be 
HIV-negative are supported with information and counseling to reduce risks and remain HIV-
negative. People, who are found to be HIV-positive, are provided psychosocial support and 
linked to treatment and care. 
 
 HCT Program results  
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 1. Activities undertaken 
 
1. The Ministry of Health in collaboration with UNICEF conducted HCT training for 
Grater Bhar El Gazal in Wau from 10-28 September 2011 for 21 days according to 
South Sudan HCT training Guidelines. A total number of 28 participants were trained 
The methodology used in the training included Group discussion, role plays and 
practices on HIV testing.   
 
2. The Ministry of Health also conducted HCT training in collaboration with International 
HIV/AIDS alliance in Yei for Central Equatoria and Eastern Equatoria from 21 
November – 10 December 2011. The curriculum used in the training was based on 
South Sudan HCT training Guidelines. A total of 23 Health providers were trained. 
  
3. The Ministry of Health in collaboration with UNICEF conducted   HCT training for the 
counselors in Malakal from 24 October – 16 November 2011. This training brought 
together 23 participants from greater Upper Nile region.  
 
4. The Ministry of Health in collaboration with Heath Net TPO conducted HCT TOT 
training in Wau from 12-28 June 2012 for 17days.  9 participants drawn from Unity, 
Western Bahr el Ghazel, and Northern Bahr el Ghazel and Warrap states were trained. 
 
5. In collaboration with UNIDO, the Ministry of Health in collaboration conducted a HCT 
training from the 17
 th
 April to 7
th
 May 2012. The participants were drawn within Unity 
state in Leer, Mayandit, penyiger, and Boau. The number of trainees was 12. 
 
 2. Number of sites 
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In 2011 a total of 34 facilities started offering HCT services in South Sudan. This brings the 
total number of facilities offering HCT services to 112 as figure 18 below shows. All these 
facilities are located in all the ten states of South Sudan and receive support from the Ministry 
of Health and partners including; Global Fund, UNICEF and PEPFAR.  
 
Figure 18 Number of HCT Sites, 2006-2011    
 
 
 
Figure 19 % of clients tested by sex, 2011 
 
 
 
 
 3. Number of Individuals Counseled and Tested  
 
The number of individuals counseled and tested increased from 66301 in 2010 to 105647 in 
2011. The data for 2011 as figure 21 above shows that females access HIV testing more than 
males. Further analysis of HIV testing data reveals females also have a higher sero-prevalence 
in all age groups except among children below 5 years as figure 20 below shows. 
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Figure 20 HIV Sero-Prevalence by sex and age groups, 2011 
 
 
 4. Challenges faced this Year 
 
 Running out of HIV Test kits 
 Inadequate qualified staff 
 Inadequate funding for training and other programmatic activities 
 
 5. Planned activities for the coming year: 
 
 Conduct 10 training workshops for 250 counselors, 25 trainees per training with support 
of  partners  
 HCT Refresher training for 25 counselors. This training will be conducted with the 
support of partners
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Chapter 6 - What I did in South Sudan (My Field Experience) 
 
With a permission from South Sudan HIV/AIDS Commission (SSAC) chairperson, Honorable, 
Dr. Esterina Novello Nyilok, and Dr. Lul Riek, Director General for community and public 
health, Ministry of Health (M.O.H), Republic of South Sudan, I was allowed to participate with 
the team to do my field experience.  Before I engaged in any field work, or practice I …. 
 
 Reviewed the strategic framework for HIV/AIDS Prevention and control in South Sudan. 
 Reviewed the strategic framework for HIV/AIDS Treatment, Management, Care and 
Support for infected/affected individuals in South Sudan. 
 Reviewed and understood the Risk Factors that potentially contribute to the transmission 
and continuing of HIV/AIDS in South Sudan. 
 
Here is what I did….. 
 
 Developed /prepared lecture notes and educated health care professionals at Ministry of 
Health (M.O.H) and South Sudan HIV/AIDS Commission (SSAC) on knowledge about 
HIV/AIDS Risk Factors, ways of transmission, prevention and control measures, 
treatment, care and support for infected individuals. 
 Raised awareness among the South Sudanese communities at ART, HCT, and PMTCT 
sites on HIV/AIDS prevention and control measures, and risky behaviors and practices 
that lead to an individual infection and spread of HIV/AIDS, adherence to treatment.  
o Used prevention education materials e.g. POSTERS to encourage them to use 
condoms during sexual acts. 
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             Figure 21HIV Counseling & Testing in Yei 
                                                                                              Figure 22 HIV Counseling & Testing in Wau 
 
 
 
 
                                           
                 Figure 23a Patients receiving ARVs at dispensary –ART site -1                    Figure 25b ART site-2 
 
                                                                                                                                     
                                    
 
 
 
o Applied Social and Behavior Basis of Public Health theories/models that I have 
learned at KSU; THE HEALTH BELIEF MODEL AND SOCIO-ECOLOGICAL 
MODEL to encourage them to engage in and practice safe behaviors.  
 
Health Belief Model: 
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Health Belief Model (HBM) is the theory I applied/used to convey knowledge about HIV/AIDS 
to South Sudanese communities during my field experience in South Sudan.  The underlying 
concept of the original Health Belief Model is that health behavior is determined by personal 
beliefs or perceptions about a disease and the strategies available to decrease its occurrence 
(Hochbaun, 1958). And, personal perception is influenced by the whole range of intrapersonal 
factors including biological and psychological factors such as genetics, cognitions, and 
personality affecting health behavior. 
The main constructs of the model are perceived seriousness, perceived susceptibility, perceived 
benefits, and perceived barriers. Each of these perceptions, individually or in combination, can 
be used to explain health behavior. In addition, more recently other constructs have been added 
to the HBM; thus, the model has been expanded to include cues to action, motivating factors, and 
self-efficacy. 
 
Perceived Susceptibility: 
  Personal risk or susceptibility is an individual’s assessment of his or her chances of getting or 
contracting the disease. It is one of the more powerful perceptions in prompting people to adopt 
healthier behaviors. The greater the perceived risk of contracting HIV and then AIDS, the greater 
the likelihood of engaging in behaviors to decrease the risk of getting HIV. It is only logical that 
when people believe they are at risk for a disease, they will be more likely to do something to 
prevent it from happening. In addition, what we have seen so far is that a perception of increased 
susceptibility or risk is linked to healthier behaviors and decreased susceptibility to unhealthy 
behaviors. This is what prompts men who have sex with multiple partners, those who are 
engaging in unsafe sex behaviors to use condoms in an effort to decrease susceptibility to HIV 
infection (Belcher et al., 2005). In South Sudan, for example, older men, in some tribes, usually 
marry naïve younger/teenager girls who perhaps are going to have the 1
st
 sex in this early age 
(early age of 1
st
 sex), since their traditions/customs/norms/cultures allow. These kinds of 
behaviors, lead to spread of HIV among these communities. Thus, when these older 
men/communities perceive risk of getting HIV infection they will change their behaviors. 
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Perceived Seriousness: 
 
This is an individual’s judgment/belief as to the severity or seriousness of the disease. While the 
perception of seriousness is often based on medical information or knowledge, it may also come 
from beliefs a person has about the difficulties a disease for example (HIV/AIDS) would create 
or the effects  it would have on his/her life in general (McCormick-Brown, 1999). For example, 
when an individual belief/perceived seriousness of AIDS complications or fate, he or she would 
probably go for counseling and testing and then enrolled in treatment, care and support before 
HIV infection develop into AIDS, thus, avoiding potential serious effects and death. 
 
Perceived Benefit: 
 
This is an individual’s conclusion/belief as to whether the new behavior is better than what he or 
she is already doing. For instance, people tend to adopt healthier behaviors when they believe the 
new behavior will decrease their chances of developing a disease. In addition, perceived benefits 
play an important role in the adoption of secondary preventive behavior as in the case of 
Voluntary Counseling and Testing (VCT) of HIV/AIDS. Here, people go through the process of 
compulsory counseling and testing, when identified as HIV positive, they are enrolled to take 
antiretroviral therapy (ART) regularly as preventive measures, thus, adopting a new behavior. 
 
Perceived Barriers: 
 
This is an individual’s opinion as to what will stop him or her from adopting the new behavior. It 
addresses the issue of perceived barriers to change. Of all the constructs, perceived barriers are 
the most significant in determining behavior change (Janz & Becker, 1984).  
In order for a new behavior to be adopted, a person needs to believe the benefits of the new 
behavior outweigh the consequences of continuing the old behavior (Centers for Disease Control 
and Prevention, 2004).This enables barriers to be overcome and the new behavior to be adopted. 
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For example, in HIV positive and AIDS patients, when perceived, the advantages of voluntary 
counseling and testing and enrollment in antiretroviral programs outweigh social stigma (fear of 
discrimination) they would adopt the new behavior. 
  
Modifying Variables:  
 
These are individual’s personal characteristics/factors that influence personal perception or that 
affects whether the new behavior is adopted. These variable/factors, such as culture, education 
level, past experiences, skill, and motivation further, influence the four major constructs of 
perception. 
 
Cues to Action: 
 
Are events, people, or things that move people to change their behavior i.e. those factors that will 
start a person on the way to changing behavior. Examples include illness of a family member, 
media reports, mass media campaigns, and advice from others, reminder postcards from health 
care provider or health warning labels on a product. For example, knowing that a family member 
previously suffered from an HIV/AIDS related complications is a significant cue to action for a 
person to seek counseling and testing for HIV/AIDS and follow the appropriate treatment, 
management, support and care for this disease.  
 
Self-efficacy: 
 
Is a personal belief in one’s own ability to do something (Bandura, 1977). People generally do 
not try to do something new unless they think they can do it. 
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 Figure 24 HIV & AIDS Prevention awareness Education Material in Wau  
                                                                                                                                               Figure 25 Part of Stakeholders forum in Juba -2011 
 
 
 
 
 
Figure 26 Association of people living with  
HIV in Nimule during WAD in Torit 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27 School children in Kajokeji participate in 
HIV campaign 
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Chapter 7 - What I will do / nest steps 
 
 7.1 society and culture and HIV/AIDS 
 
 7.1.1 Religion and HIV/AIDS 
 
Some religious organizations have claimed that prayer can cure HIV/AIDS. In 2011, the 
BBC reported that some churches in London were claiming that prayer would cure AIDS, 
and the Hackney-based Centre for the Study of Sexual Health and HIV reported that 
several people stopped taking their medication, sometimes on the direct advice of their 
pastor, priests, and other religious bodies, leading to a number of deaths.  
 
Similarly, in South Sudan, pastors, priests, and some religious organizations advise 
people to quit HIV/AIDS medications following prayers, claiming that they are cured. 
Other people travel to West African countries to attend prayers allegedly for diseases 
cure such as cancer, HIV/AIDS, high blood pressure and others. These actions result in 
people obeying pastors, priests, religious organizations orders by quitting HIV/AIDS 
medications, this in turn lead to a number of unnecessary deaths that could have been 
avoided through adherence to HIV/AIDS medication, Antiretroviral therapy (ARV,ART).  
 
Based on the above claimed, I have decided /committed to raise a heightened awareness 
on the danger/consequences of quitting HIV/AIDS medications among HIV positive and 
AIDS patients. This could be done through…. 
 
 Presentations/lectures to different communities of South Sudan to convey 
knowledge/understanding of danger/consequences of quitting HIV/AIDS 
medication. 
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       Health professionals at M.O.H and other institutions 
       Students at universities, schools 
      And also through Health Warning Signs and posters. 
 Narration or story telling for local communities. 
 Applying the Health Belief Model.  
 
 
 
 
 
 
                                             
                                                                                              Figure 29 Church processing on the street during World AIDS Day in Juba 
                                          
             
 7.1.2 Stigma 
 
HIV/AIDS stigma exists around the world in a variety of ways, including ostracism, rejection, 
discrimination and avoidance of HIV infected people; compulsory HIV testing without prior 
consent or protection of confidentiality; violence against HIV infected individuals or people who 
are perceived to be infected with HIV; and the quarantine of HIV infected individuals. Stigma-
Figure 28 Religious leaders campaigning 
for HIV and AIDS  in Kajokeji 
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related violence or the fear of violence prevents many people from seeking HIV testing, 
returning for their results, or securing treatment, possibly turning what could be a manageable 
chronic illness into a death sentence and perpetuating the spread of HIV.  
  
 
 
Ryan White became a poster child for HIV after being  
expelled from school because he was infected. 
 
Likewise, in South Sudan, HIV positive and AIDS patients are considered dead people. People 
tend to keep away from them. They believe that these people have contracted this disease 
because they have engaged in unethical/unacceptable behaviors such as prostitution, sex 
workers, and play boys, as perceived by some tribes/communities. Therefore, based on the above 
behavior, I have decided to lecture on this issue at state level, as well as small communities in 
South Sudan. 
 
 
 
Figure 30 School pupils in Kajokeji 
raising slogan calling for fighting 
against HIV Stigma &  Denial 
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 7.2 Alcohol Use and HIV/AIDS 
Alcohol-related risk behavior is common among youths, female sex workers, and in particular 
military personnel in South Sudan. Military personnel and some high rank government officials, 
when drunk, practice unsafe sex. They usually forced young girls and women to have sex 
without condoms. They threaten to take their lives if they refuse sex without condom. Such 
individuals usually contribute to the continuing spread of HIV/AIDS in South Sudan 
communities. Therefore, if I were a boss I would work together with the National Executive 
Assembly and the Judiciary System in South Sudan to find a common ground (appropriate laws) 
to prosecute these predators.  
Rough sex can be a factor associated with an increased risk of transmission. Sexual assault is 
also believed to carry an increased risk of HIV transmission as condoms are rarely worn, 
physical trauma to the vagina or rectum is likely, and there may be a greater risk of concurrent 
sexually transmitted infections.  
 
 7.3 Education on HIV/AIDS  
 
Health Officials, University Students, and school children in South Sudan need to be lectured on 
overall materials concerning HIV/AIDS at local and national levels. 
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